insulin resistance and glp-1 Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control What are the Advantages of

You can start treatment immediately without waiting weeks for prior authorization letters

Worldwide emergence of resistance to antifungal drugs challenges human health and food security

ActRII: activin type II receptors, T2D: type 2 diabetes, 6 MWD: 6-minute walk distance, GLP-1/GIP: glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide, SARMs: selective androgen receptor modulators, DMD: Duchenne muscular dystrophy, GLP-1RAs: GLP-1 receptor agonists, IGF-1: insulin-like growth factor, CV: cardiovascular Conclusions Skeletal muscle wasting is a frequent and clinically significant complication in patients with T2D and obesity, which is exacerbated by chronic inflammation, insulin resistance and metabolic dysregulation

In many ways, microdosing GLP-1s reflects a broader shift away from one-size-fits-all dosing and toward individualized care

Elvira Lange: nothing to disclose